Ichimura A, Matsumoto S, Suzuki S, Dan T, Yamaki S, Sato Y, Kiyomoto H, Ishii N, Okada K, Matsuo O, Hou FF, Vaughan DE, van Ypersele de Strihou C, Miyata T.A Small Molecule Inhibitor to
Plasminogen Activator Inhibitor 1 Inhibits Macrophage Migration.Arterioscler Thromb Vasc Biol.2013; 33(5): 935-942.
Dan T, van Ypersele de Strihou C, Miyata T. Advanced glycation end products (AGEs) inhibitor. In Oxidative Stress in Applied Basic Research and Clinical Practice Studies on Renal
Disorders, edited by Miyata T, Eckardt KU, Nangaku M. 2011
Ohtomo S, Izuhara Y, Nangaku M, Dan T, Ito S, van Ypersele de Strihou C, Miyata T. Body weight control by a high-carbohydrate/low-fat diet slows the progression of diabetic kidney damage
in an obese, hypertensive, type 2 diabetic rat model. J Obes. 2010.
Izuhara Y, Yamaoka N, Kodama H, Dan T, Takizawa S, Hirayama N, Meguro K, van Ypersele de Strihou C, Miyata T. A novel inhibitor of plasminogen activator inhibitor-1 provides
antithrombotic benefits devoid of bleeding effect in nonhuman primates. J Cereb Blood Flow Metab. 2010; 30:904-12.
Tominaga N, Robert A, Izuhara Y, Ohtomo S, Dan T, Chihara K, Kurokawa K, Van Ypersele de Strihou C, Miyata T. Very high doses of valsartan provide renoprotection independently of blood
pressure in a type 2 diabetic nephropathy rat model. Nephrology (Carlton). 2009;14(6):581-7.
Takizawa S, Dan T, Uesugi T, Nagata E, Takagi S, van Ypersele de Strihou C, Miyata T. A sartan derivative with a very low angiotensin II receptor affinity ameliorates ischemic cerebral
damage. J Cereb Blood Flow Metab. 2009;29(10):1665-72
Miyata T. and Dan T. Inhibition of advanced glycation end products (AGEs): An implicit goal in clinical medicine for the treatment of diabetic nephropathy? Diabetes research and clinical
practice 2008; 82: Suppl 1:S25-9
Izuhara Y, Sada T, Yanagisawa H, Koike H, Ohtomo S, Dan T, Ito S, Nangaku M, van Ypersele de Strihou C, and Miyata T. A novel sartan derivative with very low angiotensin II type 1 receptor
affinity protects the kidney in type 2 diabetic rats. Arterio Thromb Vas Biol 2008; 28(10):1767-73
Ohtomo S, Nangaku M, Izuhara Y, Yamada N, Dan T, Mori T, Ito S, van Ypersele C, Miyata T. The role of megsin, a serine protease inhibitor, in diabetic mesangial matrix accumulation. Kidney
Int 2008, 74(6):768-74